GLP-1 receptor agonists, such as Ozempic, Wegovy, Mounjaro, and Zepbound, have been associated with several legal actions due to alleged severe side effects and issues related to compounded versions of these medications.
Product Liability Lawsuits:
Patients have filed lawsuits against manufacturers like Novo Nordisk and Eli Lilly, alleging that the use of GLP-1 drugs led to serious gastrointestinal issues, including gastroparesis (stomach paralysis), intestinal blockages, and gallbladder damage. These lawsuits claim that the companies failed to provide adequate warnings about these potential risks. In February 2024, the Judicial Panel on Multidistrict Litigation (JPML) consolidated 55 such lawsuits into a multidistrict litigation (MDL 3094) to streamline pretrial proceedings. By December 2024, the number of pending lawsuits in this MDL had increased to 1,300.
Compounded Medication Disputes:
Compounding pharmacies have been producing and selling cheaper versions of GLP-1 drugs, particularly during periods when the original medications were listed on the FDA’s drug shortage list. Eli Lilly, the manufacturer of Mounjaro and Zepbound, has taken legal action against these pharmacies, sending cease-and-desist letters and seeking to join lawsuits to protect its patents and market share. The FDA’s decisions regarding drug shortages significantly impact the legality of these compounded versions. For instance, in late 2024, the FDA declared certain GLP-1 drugs as “available,” ending their shortage status and thereby restricting compounding pharmacies from legally preparing generic versions.
Regulatory Scrutiny:
The FDA has issued warnings about the use of unapproved compounded versions of GLP-1 drugs for weight loss, emphasizing that these unapproved versions have not undergone the agency’s review for safety, effectiveness, and quality. This regulatory stance has led to increased legal scrutiny and actions against entities involved in the distribution of compounded GLP-1 medications.
These legal and regulatory developments highlight the complexities surrounding the use of GLP-1 drugs, both in their original and compounded forms, and underscore the importance of patient awareness regarding potential side effects and the legal status of the medications they use.
Medicare Part D sponsors paid pharmacies $587.7 million for some over-the-counter drugs with obsolete prescription-only labels, despite CMS oversight. Medicare Part D does not cover OTC drugs. According to an Aug. 31 HHS Office of Inspector General report, Part D sponsors made “ineligible” payments for five drugs — more than one year after the brand-name The post Federal watchdog claims Medicare Part D sponsors paid $587.7M for over-the-counter drugs mislabeled as prescription-only appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Akerman LLP announced on Monday it has welcomed a former Steptoe LLP attorney who brings vast experience helping clients navigate a unique, complicated landscape involving Golden State consumer protection laws and regulations, including matters related to Proposition 65.
States are moving at markedly different speeds to deploy billions of dollars in new federal funding for rural healthcare. The $50 billion Rural Health Transformation Program was established under HR 1 and is administered by CMS, which will distribute $10 billion annually to all 50 states from 2026 through 2030. Each state designs and releases The post Rural Health Transformation Program funding status, by state appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Primary care physicians and advanced practice providers at Phoenix-based Banner Health have voted to unionize with the Union of American Physicians and Dentists, marking the first union among the system’s clinicians, according to a Sept. 2 news release from the union shared with Becker’s. Participating clinicians supported representation by 69% of the vote, the release The post In a 1st for Banner, physicians, advanced practice providers vote to unionize appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Generation Z is more likely than any other age group to cite their network as the most important factor in career progression, according to a Sept. 2 LinkedIn News post. The research was conducted by Censuswide between July 20 and Aug. 11 and included 18,050 professionals aged 18 to 80 who work full or part The post What matters most to Gen Z in career progression appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Medicare Part D sponsors paid pharmacies $587.7 million for some over-the-counter drugs with obsolete prescription-only labels, despite CMS oversight. Medicare Part D does not cover OTC drugs. According to an Aug. 31 HHS Office of Inspector General report, Part D sponsors made “ineligible” payments for five drugs — more than one year after the brand-name The post Federal watchdog claims Medicare Part D sponsors paid $587.7M for over-the-counter drugs mislabeled as prescription-only appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Akerman LLP announced on Monday it has welcomed a former Steptoe LLP attorney who brings vast experience helping clients navigate a unique, complicated landscape involving Golden State consumer protection laws and regulations, including matters related to Proposition 65.
States are moving at markedly different speeds to deploy billions of dollars in new federal funding for rural healthcare. The $50 billion Rural Health Transformation Program was established under HR 1 and is administered by CMS, which will distribute $10 billion annually to all 50 states from 2026 through 2030. Each state designs and releases The post Rural Health Transformation Program funding status, by state appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Primary care physicians and advanced practice providers at Phoenix-based Banner Health have voted to unionize with the Union of American Physicians and Dentists, marking the first union among the system’s clinicians, according to a Sept. 2 news release from the union shared with Becker’s. Participating clinicians supported representation by 69% of the vote, the release The post In a 1st for Banner, physicians, advanced practice providers vote to unionize appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Generation Z is more likely than any other age group to cite their network as the most important factor in career progression, according to a Sept. 2 LinkedIn News post. The research was conducted by Censuswide between July 20 and Aug. 11 and included 18,050 professionals aged 18 to 80 who work full or part The post What matters most to Gen Z in career progression appeared first on Becker's Hospital Review | Healthcare News & Analysis.